Firebrick Pharma Health Care

$0.155 0.005 (3.33%)

High $0.16	Low $0.15	Trades 7	Turnover $4,468	Volume 29,243
30 June 2023 at 3:01pm

Register to track FRE and receive email alerts.

Market Cap (19-Sep) $11,693,158 (0th)	Close (30-Jun) $0.155 0 (0%)	Volume (30-Jun) 29,243	Shortsold (14-Jul) 746 (0.00%) (620th)
52w High $0.088	52w Low $0.038	P/E -	EPS -0.01

	Subject
	FRE FRE Ann: Firebrick Update on AAT Schedule
	1 (current) 2 3
	FRE FRE Ann: Cleansing Notice
	FRE FRE Ann: Change of Director's Interest Notice - Stephen Goodall
	FRE FRE Ann: Change of Director's Interest Notice - Peter Molloy
	FRE FRE Ann: Application for quotation of securities - FRE
	FRE FRE Ann: Results of General Meeting
	FRE FRE Ann: Firebrick Pharma Investor Update on Key Projects
	FRE FRE Ann: Notification of cessation of securities - FRE
	FRE FRE Ann: Nasodine Phase 3 Clinical Trial Surpasses 80% Recruitment
	FRE FRE Ann: Update on Nasodine AAT Appeal Timetable
	FRE FRE Ann: Letter to Shareholders & Notice of GM & Proxy Form
	FRE FRE Ann: Cleansing Notice
	FRE FRE Ann: Application for quotation of securities - FRE
	FRE FRE Ann: Nasodine Patent Allowed in Canada
	FRE FRE Ann: Proposed issue of securities - FRE
	FRE FRE Ann: Proposed issue of securities - FRE
	FRE FRE Ann: Firebrick Raises $1 million via Placement
	FRE FRE Ann: March 2023 Quarterly Activity Report & Appendix 4C
	FRE FRE Ann: Nasodine COVID-19 Trial Concludes Recruitment
	FRE FRE Ann: Cleansing Notice
	FRE FRE Ann: Application for quotation of securities - FRE
	FRE FRE Ann: Firebrick Pharma's Phase 3 Trial of Nasodine Resumes
	FRE FRE Ann: FRE files EU Paediatric Investigation Plan for Nasodine
	FRE FRE Ann: Appendix 4D & Half Yearly Report and Accounts
	FRE FRE Ann: Investor Presentation - Euroz Hartleys Healthcare Forum
	FRE FRE Ann: December 2022 Quarterly Activity Report & Appendix 4C
	FRE FRE Ann: Nasodine Research Points to Potential Role in CRS
	FRE FRE Ann: Nasodine Appeal Timetable Agreed at AAT Conference
	FRE FRE Ann: Change of Director's Interest Notice - Phyllis Gardner
	FRE FRE Ann: Change of Director's Interest Notice - Richard Treagus
	FRE FRE Ann: Notification regarding unquoted securities - FRE
	FRE FRE Ann: Notification regarding unquoted securities - FRE
	FRE FRE Ann: Constitution
	FRE FRE Ann: Results of Annual General Meeting
	FRE FRE Ann: Annual General Meeting Presentation
	FRE FRE Ann: Firebrick CFO and Accounting Change
	FRE FRE Ann: Nasodine Composition Patent Accepted in Australia
	FRE FRE Ann: Firebrick Receives $1.08m R&D Tax Incentive
	FRE FRE Ann: Proposed issue of securities - FRE
	FRE FRE Ann: Firebrick Update on Nasodine Phase 3 Trial
	FRE FRE Ann: September 2022 Quarterly Activity Report & Appendix 4C
	FRE FRE Ann: Nasodine Patent Granted in Singapore
	FRE FRE Ann: Annual Report to Shareholders
	FRE FRE Ann: Letter to Shareholders & Notice of AGM & Proxy Form
	FRE FRE Ann: Notification of cessation of securities - FRE
	FRE FRE Ann: Notice of AGM and Closing Date for Director Nominations
	FRE FRE Ann: Firebrick announces formation of Scientific Advisory Board
	FRE FRE Ann: Corporate Governance Statement
	FRE FRE Ann: Appendix 4G
	FRE FRE Ann: Appendix 4E & Annual Report

Register to track FRE and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.07	86,441	0.00 (4.41%)
12-Sep	$0.07	9,012	+0.00 (4.62%)
11-Sep	$0.07	74,462	-0.01 (8.45%)
05-Sep	$0.07	135,388	0.00 (0.00%)
04-Sep	$0.07	157	0.00 (0.00%)
03-Sep	$0.07	13,158	0.00 (5.33%)
29-Aug	$0.08	0	0.00 (0.00%)
28-Aug	$0.08	0	0.00 (0.00%)
22-Aug	$0.08	174,657	0.00 (0.00%)
21-Aug	$0.08	317,245	-0.01 (6.25%)
15-Aug	$0.08	29,901	+0.00 (1.27%)
14-Aug	$0.08	0	0.00 (1.25%)
07-Aug	$0.08	0	+0.00 (3.90%)
31-Jul	$0.08	85,467	0.00 (3.75%)
30-Jul	$0.08	51,750	+0.00 (3.90%)
4 up, 6 down, and 5 flat days